science

6 Things To Know About The Class Of 2025

Christine Y. Cruzvergara, Contributor, Christine Y. Cruzvergara, Contributor https://www.forbes.com/sites/christinecruzvergara/

Having faced multiple challenges in their collegiate career, the Class of 2025 approaches the job ... More search with resiliency and determination. getty The Class of 2025 has traveled a long and ...[Continue Reading]

Forbes

1 day ago

Recent News (Science)

science

Benchmarking the climate mitigation potential of BECCS [Promoted content]

Dr Caroline Gaudreault

The role of BECCS in meeting global climate targets As the world grapples with the escalating climate crisis, it is becoming increasingly clear that reducing greenhouse gas (GHG) emissions alone wi ...[Continue Reading]

EURACTIV

1 day ago

science

Augustine Therapeutics builds its Management Team with Virginie Cartage joining as CFO and Dr. Andy Hu as CBO

Augustine Therapeutics

Augustine Therapeutics builds its Management Team with Virginie Cartage joining as CFO and Dr. Andy Hu as CBO <ul><li>New recruits expand senior team capabilities as the business progresses its lead ...[Continue Reading]

GlobeNewswire

1 day ago


science

dsm-firmenich Q1 2025 trading update

dsm-firmenich

Press ReleaseKaiseraugst (Switzerland), Maastricht (Netherlands), April 30, 2025 dsm-firmenich Q1 2025 trading update Management Report Q1 2025 highlights <ul><li>Good start to the year with str ...[Continue Reading]

GlobeNewswire

1 day ago


science

CHMP recommends EU label update for Roches Phesgo to allow administration outside of clinical settings

F. Hoffmann-La Roche Ltd

<ul><li>Positive recommendation based on clinical, real-world and bioequivalence datasupporting feasibility and safety of Phesgos administration outside of clinical settings, for example at home1-4< ...[Continue Reading]

GlobeNewswire

1 day ago


science

Idorsia announces financial results for the first quarter 2025 QUVIVIQ taking off in Europe and TRYVIO REMS removal increases the value of this outstanding asset

Idorsia Pharmaceuticals Ltd

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland April 30, 2025Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2025. Business highlights Q1 2 ...[Continue Reading]

GlobeNewswire

1 day ago